Episode 11 of the Oncology Hour Podcast features a conversation with John Hallick on Lung cancer, MET mutations, and why patients should be aware of biomarker testing and clinical trial options.

John Hallick is a lung cancer survivor and founder of the MET Crusaders, who are a community of lung cancer patients, care givers, advocates, researchers, and physicians dedicated to helping patients with the MET alteration live normal lives.